Owc Pharmaceutical ResearchOWCP
13F holders, Q1 2024 (March 31)1holders
$0.00avg. 13F price*
At the end of Q1 2024, 1 institutions reported holding Owc Pharmaceutical Research (OWCP) in their 13F filings. The largest holder was Front Row Advisors LLC ($0).
- Company
- Owc Pharmaceutical Research
- CUSIP
- 67109N108
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024
No earlier quarter to compare with.
Ownership 1 holders
| Front Row Advisors LLC | 0.00% | No change | 1,500 | $0 |
"% of holder's portfolio" is OWCP's weight in each manager's 13F, not the share of Owc Pharmaceutical Research the manager owns.